A Drug Discovery Approach to a Reveal Novel Antioxidant Natural Source: The Case of Chestnut Burr Biomass
Abstract
:1. Introduction
2. Results
2.1. LC-DAD-MS Analyses
2.2. In Silico Results
2.2.1. Target/Compound Virtual Screening
2.2.2. cMD: Target/Ellagic Acid’s Docking Pose Stability and Interaction Energy
2.2.3. SMD: Target/Ellagic Acid’s Unbinding Pathway
3. Discussion
4. Materials and Methods
4.1. Materials and Samples
4.2. C. sativa Chestnut Burrs Extract Preparation
4.3. LC-DAD Analysis
4.4. Structural Optimization and Resources
4.5. Virtual Screening
4.6. Steered Molecular Dynamics (SMD) Simulations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Bongaarts, J. Human population growth and the demographic transition. Philos. Trans. R. Soc. B Biol. Sci. 2009, 364, 2985–2990. [Google Scholar] [CrossRef] [PubMed]
- Dewulf, J.; Benini, L.; Mancini, L.; Sala, S.; Blengini, G.A.; Ardente, F.; Recchioni, M.; Maes, J.; Pant, R.; Pennington, D. Rethinking the area of protection “natural resources” in life cycle assessment. Environ. Sci. Technol. 2015, 49, 5310–5317. [Google Scholar] [CrossRef] [PubMed]
- Di Vaio, A.; Hasan, S.; Palladino, R.; Hassan, R. The transition towards circular economy and waste within accounting and accountability models: A systematic literature review and conceptual framework. Environ. Dev. Sustain. 2023, 25, 734–810. [Google Scholar] [CrossRef]
- Nagarajan, D.; Lee, D.J.; Chang, J.S. Circular Bioeconomy: An Introduction. In Biomass, Biofuels, Biochemicals: Circular Bioeconomy-Current Developments and Future Outlook; Elsevier: Amsterdam, The Netherlands, 2021; pp. 3–23. [Google Scholar]
- Venkatesh, G. Circular Bio-economy—Paradigm for the Future: Systematic Review of Scientific Journal Publications from 2015 to 2021. Circ. Econ. Sustain. 2022, 2, 231–279. [Google Scholar] [CrossRef]
- Leong, H.Y.; Chang, C.K.; Khoo, K.S.; Chew, K.W.; Chia, S.R.; Lim, J.W.; Chang, J.S.; Show, P.L. Waste biorefinery towards a sustainable circular bioeconomy: A solution to global issues. Biotechnol. Biofuels 2021, 14, 87. [Google Scholar] [CrossRef]
- Alexandri, M.; López-Gómez, J.P.; Olszewska-Widdrat, A.; Venus, J. Valorising agro-industrial wastes within the circular bioeconomy concept: The case of defatted rice bran with emphasis on bioconversion strategies. Fermentation 2020, 6, 42. [Google Scholar] [CrossRef]
- Pinto, D.; Braga, N.; Silva, A.M.; Costa, P.; Delerue-Matos, C.; Rodrigues, F. Valorization of Fruit Processing By-Products; Academic Press: Cambridge, MA, USA, 2019; pp. 128–141. [Google Scholar]
- Silva, V.; Falco, V.; Dias, M.I.; Barros, L.; Silva, A.; Capita, R.; Poeta, P. Evaluation of the phenolic profile of Castanea sativa Mill. by-products and their antioxidant and antimicrobial activity against multiresistant bacteria. Antioxidants 2020, 9, 87. [Google Scholar] [CrossRef]
- Neves, J.M.; Matos, C.; Moutinho, C.; Queiroz, G.; Gomes, L.R. Ethnopharmacological notes about ancient uses of medicinal plants in Trás-os-Montes (northern of Portugal). J. Ethnopharmacol. 2009, 124, 270–283. [Google Scholar] [CrossRef]
- Corregidor, V.; Antonio, A.L.; Alves, L.C.; Cabo Verde, S. Castanea sativa shells and fruits: Compositional analysis by proton induced X-ray emission. Nucl. Instrum. Methods Phys. Res. Sect. B Beam Interact. Mater. Atoms 2020, 477, 98–103. [Google Scholar] [CrossRef]
- Comandini, P.; Lerma-García, M.J.; Simó-Alfonso, E.F.; Toschi, T.G. Tannin analysis of chestnut bark samples (Castanea sativa Mill.) by HPLC-DAD-MS. Food Chem. 2014, 157, 290–295. [Google Scholar] [CrossRef]
- De Vasconcelos, M.C.; Bennett, R.N.; Rosa, E.A.; Ferreira-Cardoso, J.V. Composition of European Chestnut (Castanea sativa Mill.) and Association with Health Effects: Fresh and Processed Products. J. Sci. Food Agric. 2010, 90, 1578–1589. [Google Scholar] [CrossRef]
- Antonio, A.L.; Carocho, M.; Bento, A.; Quintana, B.; Luisa Botelho, M.; Ferreira, I.C.F.R. Effects of gamma radiation on the biological, physico-chemical, nutritional and antioxidant parameters of chestnuts—A review. Food Chem. Toxicol. 2012, 50, 3234–3242. [Google Scholar] [CrossRef]
- Spiga, O.; Cicaloni, V.; Fiorini, C.; Trezza, A.; Visibelli, A.; Millucci, L.; Bernardini, G.; Bernini, A.; Marzocchi, B.; Braconi, D.; et al. Machine learning application for development of a data-driven predictive model able to investigate quality of life scores in a rare disease. Orphanet J. Rare Dis. 2020, 15, 46. [Google Scholar] [CrossRef] [PubMed]
- Spiga, O.; Cicaloni, V.; Zatkova, A.; Millucci, L.; Bernardini, G.; Bernini, A.; Marzocchi, B.; Bianchini, M.; Zugarini, A.; Rossi, A.; et al. A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria. Comput. Biol. Med. 2018, 103, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Wishart, D.S.; Feunang, Y.D.; Guo, A.C.; Lo, E.J.; Marcu, A.; Grant, J.R.; Sajed, T.; Johnson, D.; Li, C.; Sayeeda, Z.; et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 2018, 46, D1074–D1082. [Google Scholar] [CrossRef]
- Johnson, M.; Zaretskaya, I.; Raytselis, Y.; Merezhuk, Y.; McGinnis, S.; Madden, T.L. NCBI BLAST: A better web interface. Nucleic Acids Res. 2008, 36, W5–W9. [Google Scholar] [CrossRef]
- Trezza, A.; Mugnaini, C.; Corelli, F.; Santucci, A.; Spiga, O. In silico Multi-Target Approach Revealed Potential Lead Compounds as Scaffold for the Synthesis of Chemical Analogues Targeting SARS-CoV-2. Biology 2022, 11, 465. [Google Scholar] [CrossRef]
- Piazza, S.; Martinelli, G.; Fumagalli, M.; Pozzoli, C.; Maranta, N.; Giavarini, F.; Colombo, L.; Nicotra, G.; Vicentini, S.F.; Genova, F.; et al. Ellagitannins from Castanea sativa Mill. Leaf Extracts Impair H. pylori Viability and Infection-Induced Inflammation in Human Gastric Epithelial Cells. Nutrients 2023, 15, 1504. [Google Scholar] [CrossRef]
- Liberti, A.; Goretti, G.; Russo, M.V. PCDD and PCDF formation in the combustion of vegetable wastes. Chemosphere 1983, 12, 661–663. [Google Scholar] [CrossRef]
- Peng, Y.H.; Shiao, H.Y.; Tu, C.H.; Liu, P.M.; Hsu, J.T.A.; Amancha, P.K.; Wu, J.S.; Coumar, M.S.; Chen, C.H.; Wang, S.Y.; et al. Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: The role of the DFG motif in the design of epidermal growth factor receptor inhibitors. J. Med. Chem. 2013, 56, 3889–3903. [Google Scholar] [CrossRef]
- Arter, C.; Trask, L.; Ward, S.; Yeoh, S.; Bayliss, R. Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors. J. Biol. Chem. 2022, 298, 102247. [Google Scholar] [CrossRef]
- Yousuf, M.; Shamsi, A.; Khan, P.; Shahbaaz, M.; Alajmi, M.F.; Hussain, A.; Hassan, G.M.; Islam, A.; Haque, Q.M.R.; Hassan, M.I. Ellagic acid controls cell proliferation and induces apoptosis in breast cancer cells via inhibition of cyclin-dependent kinase 6. Int. J. Mol. Sci. 2020, 21, 3526. [Google Scholar] [CrossRef]
- Baier, A.; Szyszka, R. Compounds from natural sources as protein kinase inhibitors. Biomolecules 2020, 10, 1546. [Google Scholar] [CrossRef]
- Dahiya, R.; Mohammad, T.; Gupta, P.; Haque, A.; Alajmi, M.F.; Hussain, A.; Hassan, M.I. Molecular interaction studies on ellagic acid for its anticancer potential targeting pyruvate dehydrogenase kinase 3. RSC Adv. 2019, 9, 23302–23315. [Google Scholar] [CrossRef]
- Sekiguchi, Y.; Nakaniwa, T.; Kinoshita, T.; Nakanishi, I.; Kitaura, K.; Hirasawa, A.; Tsujimoto, G.; Tada, T. Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid. Bioorg. Med. Chem. Lett. 2009, 19, 2920–2923. [Google Scholar] [CrossRef]
- Berman, H.M.; Battistuz, T.; Bhat, T.N.; Bluhm, W.F.; Bourne, P.E.; Burkhardt, K.; Feng, Z.; Gilliland, G.L.; Iype, L.; Jain, S.; et al. The protein data bank. Acta Crystallogr. Sect. D Biol. Crystallogr. 2002, 58 Pt 6, 899–907. [Google Scholar] [CrossRef] [PubMed]
- Bateman, A.; Martin, M.J.; O’Donovan, C.; Magrane, M.; Apweiler, R.; Alpi, E.; Antunes, R.; Arganiska, J.; Bely, B.; Bingley, M.; et al. UniProt: A hub for protein information. Nucleic Acids Res. 2015, 43, D204–D212. [Google Scholar]
- Janson, G.; Paiardini, A. PyMod 3: A complete suite for structural bioinformatics in PyMOL. Bioinformatics 2021, 37, 1471–1472. [Google Scholar] [CrossRef]
- Laskowski, R.A.; MacArthur, M.W.; Moss, D.S.; Thornton, J.M. PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26, 283–291. [Google Scholar] [CrossRef]
- Berendsen, H.J.C.; van der Spoel, D.; van Drunen, R. GROMACS: A message-passing parallel molecular dynamics implementation. Comput. Phys. Commun. 1995, 91, 43–56. [Google Scholar] [CrossRef]
- Vanommeslaeghe, K.; Hatcher, E.; Acharya, C.; Kundu, S.; Zhong, S.; Shim, J.; Darian, E.; Guvench, O.; Lopes, P.; Vorobyov, I.; et al. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 2010, 31, 671–690. [Google Scholar] [CrossRef]
- Jo, S.; Kim, T.; Iyer, V.G.; Im, W. CHARMM-GUI: A web-based graphical user interface for CHARMM. J. Comput. Chem. 2008, 29, 1859–1865. [Google Scholar] [CrossRef]
- Morris, G.M.; Ruth, H.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell, D.S.; Olson, A.J. Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009, 30, 2785–2791. [Google Scholar] [CrossRef] [PubMed]
- Fusi, F.; Trezza, A.; Spiga, O.; Sgaragli, G.; Bova, S. Cav1.2 channel current block by the PKA inhibitor H-89 in rat tail artery myocytes via a PKA-independent mechanism: Electrophysiological, functional, and molecular docking studies. Biochem. Pharmacol. 2017, 140, 53–63. [Google Scholar] [CrossRef] [PubMed]
- O’Boyle, N.M.; Banck, M.; James, C.A.; Morley, C.; Vandermeersch, T.; Hutchison, G.R. Open Babel: An Open chemical toolbox. J. Cheminform. 2011, 3, 33. [Google Scholar] [CrossRef] [PubMed]
- Fusi, F.; Durante, M.; Spiga, O.; Trezza, A.; Frosini, M.; Floriddia, E.; Teodori, E.; Dei, S.; Saponara, S. In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug resistance-reverting agents. Naunyn. Schmiedebergs. Arch. Pharmacol. 2016, 389, 1033–1043. [Google Scholar] [CrossRef] [PubMed]
- Kim, S.; Chen, J.; Cheng, T.; Gindulyte, A.; He, J.; He, S.; Li, Q.; Shoemaker, B.A.; Thiessen, P.A.; Yu, B.; et al. PubChem 2019 update: Improved access to chemical data. Nucleic Acids Res. 2019, 47, D1102–D1109. [Google Scholar] [CrossRef] [PubMed]
- Sievers, F.; Wilm, A.; Dineen, D.; Gibson, T.J.; Karplus, K.; Li, W.; Lopez, R.; McWilliam, H.; Remmert, M.; Söding, J.; et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 2011, 7, 539. [Google Scholar] [CrossRef] [PubMed]
- Guerra, B.; Issinger, O.G. Natural Compounds and Derivatives as Ser/Thr Protein Kinase Modulators and Inhibitors. Pharmaceuticals 2019, 12, 4. [Google Scholar] [CrossRef] [PubMed]
- Tošović, J.; Bren, U. Antioxidative action of ellagic acid—A kinetic DFT study. Antioxidants 2020, 9, 587. [Google Scholar] [CrossRef]
- Xiao, Y.; Huang, R.; Wang, N.; Deng, Y.; Tan, B.; Yin, Y.; Qi, M.; Wang, J. Ellagic acid alleviates oxidative stress by mediating Nrf2 signaling pathways and protects against paraquat-induced intestinal injury in piglets. Antioxidants 2022, 11, 252. [Google Scholar] [CrossRef]
- Romeo, I.; Vallarino, G.; Turrini, F.; Roggeri, A.; Olivero, G.; Boggia, R.; Alcaro, S.; Costa, G.; Pittaluga, A. Presynaptic release-regulating alpha2 autoreceptors: Potential molecular target for ellagic acid nutraceutical properties. Antioxidants 2021, 10, 1759. [Google Scholar] [CrossRef] [PubMed]
- De Souza Tavares, W.; Pena, G.R.; Martin-Pastor, M.; de Sousa, F.F.O. Design and characterization of ellagic acid-loaded zein nanoparticles and their effect on the antioxidant and antibacterial activities. J. Mol. Liq. 2021, 341, 116915. [Google Scholar] [CrossRef]
- Amor, A.J.; Gómez-Guerrero, C.; Ortega, E.; Sala-Vila, A.; Lázaro, I. Ellagic acid as a tool to limit the diabetes burden: Updated evidence. Antioxidants 2020, 9, 1226. [Google Scholar] [CrossRef] [PubMed]
- Umar, A.K.; Zothantluanga, J.H.; Aswin, K.; Maulana, S.; Sulaiman Zubair, M.; Lalhlenmawia, H.; Rudrapal, M.; Chetia, D. Antiviral phytocompounds “ellagic acid” and “(+)-sesamin” of Bridelia retusa identified as potential inhibitors of SARS-CoV-2 3CL pro using extensive molecular docking, molecular dynamics simulation studies, binding free energy calculations, and bioactivity prediction. Struct. Chem. 2022, 33, 1445–1465. [Google Scholar] [PubMed]
- Javaid, N.; Shah, M.A.; Rasul, A.; Chauhdary, Z.; Saleem, U.; Khan, H.; Ahmed, N.; Uddin, M.S.; Mathew, B.; Behl, T.; et al. Neuroprotective effects of ellagic acid in Alzheimer’s disease: Focus on underlying molecular mechanisms of therapeutic potential. Curr. Pharm. Des. 2021, 27, 3591–3601. [Google Scholar] [CrossRef]
- Mohammadinejad, A.; Mohajeri, T.; Aleyaghoob, G.; Heidarian, F.; Kazemi Oskuee, R. Ellagic acid as a potent anticancer drug: A comprehensive review on in vitro, in vivo, in silico, and drug delivery studies. Biotechnol. Appl. Biochem. 2022, 69, 2323–2356. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Trezza, A.; Geminiani, M.; Cutrera, G.; Dreassi, E.; Frusciante, L.; Lamponi, S.; Spiga, O.; Santucci, A. A Drug Discovery Approach to a Reveal Novel Antioxidant Natural Source: The Case of Chestnut Burr Biomass. Int. J. Mol. Sci. 2024, 25, 2517. https://doi.org/10.3390/ijms25052517
Trezza A, Geminiani M, Cutrera G, Dreassi E, Frusciante L, Lamponi S, Spiga O, Santucci A. A Drug Discovery Approach to a Reveal Novel Antioxidant Natural Source: The Case of Chestnut Burr Biomass. International Journal of Molecular Sciences. 2024; 25(5):2517. https://doi.org/10.3390/ijms25052517
Chicago/Turabian StyleTrezza, Alfonso, Michela Geminiani, Giuseppe Cutrera, Elena Dreassi, Luisa Frusciante, Stefania Lamponi, Ottavia Spiga, and Annalisa Santucci. 2024. "A Drug Discovery Approach to a Reveal Novel Antioxidant Natural Source: The Case of Chestnut Burr Biomass" International Journal of Molecular Sciences 25, no. 5: 2517. https://doi.org/10.3390/ijms25052517